Teva Pharma (TEVA) Lowers Quarterly Dividend 75% to $0.085; 1.1% Yield

Go back to Teva Pharma (TEVA) Lowers Quarterly Dividend 75% to $0.085; 1.1% Yield

Teva Reports Second Quarter 2017 Financial Results

August 3, 2017 6:30 AM EDT

Revenues of $5.7 billion GAAP EPS loss of $5.94 Non-GAAP EPS of $1.02 2017 business outlook revised to non-GAAP EPS of $4.30 - $4.50 Teva announces second quarter 2017 dividend of 8.5 cents,
down 75% from 34 cents in the first quarter of 2017

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2017.

Second quarter results were lower than we anticipated due to... More